Coronary artery disease after heart transplantation: timing of coronary arteriography. 1993

A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
Thoraxcenter, University Hospital Rotterdam-Dijkzigt, Erasmus University, The Netherlands.

The increasing numbers of long-term survivors after heart transplantation make yearly coronary arteriography, used by most centers to study the development of transplant coronary artery disease, less practical. Therefore the prevalence and clinical relevance of coronary artery disease in 119 one-year survivors of heart transplantation were studied. Visual analysis revealed two main patterns of vascular changes: abnormalities of the epicardial vessels and their major branches and abnormalities of the tertiary branches. The prevalence of all abnormalities in the coronary vascular tree increased from 34% after 1 year to 79% after 5 years. The prevalence of anatomically significant lesions (more than 50% stenosis in the epicardial branches or abrupt ending/proximal occlusion of tertiary branches) was only 11% after 5 years. During follow-up of 25 to 87 (median, 43) months, no significant coronary artery disease developed in the 101 patients who showed normal epicardial vessels or abnormal tertiary branches only at their first year angiography, and none of the patients died of ischemic heart disease. Of the 18 patients with abnormal epicardial vessels, three patients died of ischemic heart disease; one of these patients was treated with atherectomy and is alive at the moment of this report, and two patients showed progression of discrete lesions without evidence of ischemia until now. Based on these findings, a schedule for timing of arteriography was developed depending on the first-year coronary findings.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
September 1992, British heart journal,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
January 2000, Comprehensive therapy,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
February 2022, Cardiology in the young,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
March 1967, Geriatrics,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
October 1974, Journal of the Royal College of Physicians of London,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
December 2004, Transplant immunology,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
November 1999, American heart journal,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
October 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
January 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
A H Balk, and M L Simoons, and M J vd Linden, and P J de Feyter, and B Mochtar, and W Weimar, and E Bos
July 1974, The American journal of roentgenology, radium therapy, and nuclear medicine,
Copied contents to your clipboard!